Keywords: Sanofi-Aventis, Jevtana US launch, Genzyme takeover speculation

Sanofi-Aventis debuts prostate cancer drug Jevtana in USA; Genzyme takeover still mooted

Article | 27 July 2010

Print This

Sanofi-Aventis recently announced the launch of its oncology drug, Jevtana (cabazitaxel), in the US. The product launch comes a month ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in